Posts in category

In Depth


NSW PDL Director Curtis Ruhnau takes a look at some of the more common areas of potential risk that PDL regularly sees. Patient profile and prescription intake Patient profile and …

Weekly Dose: sofosbuvir – what’s the price of a hepatitis C cure? Greg Dore, UNSW Australia and Marianne Martinello, UNSW Australia Sofosbuvir is one of a number of new direct-acting …

Despite the gloom settling over the pharmacy sector, there’s actually more opportunities out there than ever, writes Karalyn Huxhagen Opportunities for those of us pharmacists of a more mature age …

Health Check: should we be using alcohol-based hand sanitisers? Mary-Louise McLaws, UNSW Australia They’re everywhere in hospitals, travellers’ backpacks and the aisles of pharmacies in winter, but do we really …

Debbie Rigby’s roundup of the latest news in the research world Zinc acetate lozenges for treating the common cold A meta-analysis of randomised controlled trials has concluded that zinc acetate …

Whether capturing the myriad wildlife in the game parks of Kruger and Chobe, the truly awesome sight of Victoria Falls, the fun of Africa’s pleasure capital Sun City, the sensational …

Many people need more help than you’d expect in taking care of their oral health, writes Karalyn Huxhagen Community pharmacy contributes to dental and oral health in many ways: Tooth …

The King Review discussion paper poses no fewer than 140 questions about virtually every aspect of Australia’s community pharmacy model, says George Tambassis. But it omitted one key question: should …

Weekly Dose: fentanyl, the anaesthetic that may have been used as a chemical weapon on Chechen rebels Nial Wheate, University of Sydney Fentanyl is a synthetic analgesic (pain relieving) drug …

Pharmacy is under a lot of pressure, writes Mouhamad Zoghbi—but does keeping worries to yourself help your team? I’d like tell you about something that happened at my home recently. …

Debbie Rigby presents the latest research news relevant to pharmacy Heart Failure Outcomes With Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk In patients with type 2 …

Health Check: what your pee and poo colour says about your health Clare Collins, University of Newcastle; Kristine Pezdirc, University of Newcastle, and Megan Rollo, University of Newcastle Out of …